サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1147904

細胞・遺伝子治療ツールおよび試薬の世界市場

Cell and Gene Therapy Tools and Reagents: Global Markets
出版日: | 発行: BCC Research | ページ情報: 英文 139 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
細胞・遺伝子治療ツールおよび試薬の世界市場
出版日: 2022年10月31日
発行: BCC Research
ページ情報: 英文 139 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の細胞・遺伝子治療ツールおよび試薬の市場規模は、2022年の83億米ドルから、2027年には137億米ドルに成長し、2022年から2027年までのCAGRは10.6%と予測されています。

北米地域は、2022年の37億米ドルから、2027年には66億米ドルに成長し、2022年から2027年までのCAGRは12.2％と予測されています。また、欧州地域は、2022年の21億米ドルから、2027年には35億米ドルに成長し、2022年から2027年までのCAGRは10.2％と予測されています。

当レポートでは、世界の細胞・遺伝子治療ツールおよび試薬の市場を調査し、市場および技術の背景、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、法規制環境、特許動向、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 市場および技術の背景

  • 概要：細胞・遺伝子治療
    • 細胞治療
    • 遺伝子治療
  • 細胞・遺伝子治療のタイプ
    • 遺伝子治療
    • 細胞治療
    • 治療の進化と拡大
    • 使用される一般的な機器

第4章 市場力学

  • 市場影響要因
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • COVID-19の影響

第5章 市場内訳：用途別

  • 細胞・遺伝子治療ツールおよび試薬市場
  • 癌
  • 希少疾患
  • その他

第6章 市場内訳：エンドユーザー別

  • バイオテクノロジー・製薬会社
  • 学術・研究機関
  • 臨床ラボ・病院
  • GMPタンパク質

第7章 市場内訳：タイプ別

  • GMPタンパク質
    • 用途別
    • エンドユーザー別
  • 培地
    • 用途別
    • エンドユーザー別
  • 細胞分離
    • 用途別
    • エンドユーザー別
  • 細胞増殖
    • 用途別
    • エンドユーザー別
  • ベクター
    • 用途別
    • エンドユーザー別
  • GMP低分子
    • 用途別
    • エンドユーザー別
  • GMP抗体
    • 用途別
    • エンドユーザー別
  • 白血球除去
    • 用途別
    • エンドユーザー別
  • 凍結保存
    • 用途別
    • エンドユーザー別
  • バイオリアクター
    • 用途別
    • エンドユーザー別
  • イムノアッセイ・マルチプレックスイムノアッセイ
    • 用途別
    • エンドユーザー別
  • サイトカイン放出試験
    • 用途別
    • エンドユーザー別

第8章 市場内訳：地域別

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第9章 政府規制

  • 遺伝子治療に関する規制の範囲

第10章 特許レビュー/新たな開発

  • 細胞・遺伝子治療のR&D
  • 技術

第11章 競合情勢

  • M&A
  • 競合分析

第12章 企業プロファイル

  • ABCAM
  • AKRON BIOTECH
  • ADVERUM BIOTECHNOLOGIES
  • ATHERSYS INC.
  • AVROBIO
  • BIO-RAD LABORATORIES
  • BIO-TECHNE
  • CELLGENIX
  • CYTIVA LIFE SCIENCES
  • FUJIFILM IRVINE SCIENTIFIC
  • LUMINEX CORP.
  • MESOBLAST LTD.
  • MERCK KGAA
  • MILTENYI BIOTEC
  • ORGANICELL
  • PROTEINTECH GROUP INC.
  • SARTORIUS
  • SINO BIOLOGICAL INC.
  • STEMCELL TECHNOLOGIES
  • THERMO FISHER SCIENTIFIC
図表

List of Tables

  • Summary Table A : Global Market for Cell and Gene Therapy Tools and Reagents, Through 2027
  • Summary Table B : Global Market for Cell and Gene Therapy Tools and Reagents, by Region, Through 2027
  • Table 1 : Global Cancer Statistics, 2020
  • Table 2 : Global Market for Cell and Gene Therapy Tools and Reagents, Through 2027
  • Table 3 : Global Cell and Gene Therapy Tools and Reagents Market, by Application, Through 2027
  • Table 4 : Global Cell and Gene Therapy Tools and Reagents Market for Cancer, by Region, Through 2027
  • Table 5 : Global Cell and Gene Therapy Tools and Reagents for Rare Diseases, by Region, Through 2027
  • Table 6 : Global Cell and Gene Therapy Tools and Reagents for Other Diseases, by Region, Through 2027
  • Table 7 : Global Cell and Gene Therapy Tools and Reagents Market, by End User, Through 2027
  • Table 8 : Global Cell and Gene Therapy Tools and Reagents for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
  • Table 9 : Global Cell and Gene Therapy Tools and Reagents Market for Academic and Research Institutes, by Region, Through 2027
  • Table 10 : Global Cell and Gene Therapy Tools and Reagents Market for Clinical Laboratories, by Region, Through 2027
  • Table 11 : Global Cell and Gene Therapy Tools and Reagents Market, by Type, Through 2027
  • Table 12 : Global Market for GMP Proteins, by Region, Through 2027
  • Table 13 : Global Market for GMP Proteins for Cancer, by Region, Through 2027
  • Table 14 : Global Market for GMP Proteins for Rare Diseases, by Region, Through 2027
  • Table 15 : Global Market for GMP Proteins for Other Diseases, by Region, Through 2027
  • Table 16 : Global Market for GMP Proteins for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
  • Table 17 : Global Market for GMP Proteins for Academic and Research Institutes, by Region, Through 2027
  • Table 18 : Global Market for GMP Proteins for Clinical Laboratories and Hospitals, by Region, Through 2027
  • Table 19 : Global Market for Media, by Region, Through 2027
  • Table 20 : Global Market for Cancer Media, by Region, Through 2027
  • Table 21 : Global Market for Media for Rare Diseases, by Region, Through 2027
  • Table 22 : Global Market for Media for Other Diseases, by Region, Through 2027
  • Table 23 : Global Market for Media for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
  • Table 24 : Global Market for Media for Academic and Research Institutes, by Region, Through 2027
  • Table 25 : Global Market for Clinical Laboratory and Hospital Media, by Region, Through 2027
  • Table 26 : Global Market for Cell Separation, by Region, Through 2027
  • Table 27 : Global Market for Cancer Cell Separation, by Region, Through 2027
  • Table 28 : Global Market for Rare Disease Cell Separation, by Region, Through 2027
  • Table 29 : Global Market for Cell Separation for Other Diseases, by Region, Through 2027
  • Table 30 : Global Market for Cell Separation, Pharmaceutical and Biotechnology Companies, by Region, Through 2027
  • Table 31 : Global Market for Cell Separation, Academic and Research Institutes, by Region, Through 2027
  • Table 32 : Global Market for Cell Separation, Clinical Laboratories and Hospitals, by Region, Through 2027
  • Table 33 : Global Market for Cell Expansion, by Region, Through 2027
  • Table 34 : Global Market for Cell Expansion for Cancer, by Region, Through 2027
  • Table 35 : Global Market for Cell Expansion for Rare Diseases, by Region, Through 2027
  • Table 36 : Global Market for Cell Expansion for Other Diseases, by Region, Through 2027
  • Table 37 : Global Market for Cell Expansion for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
  • Table 38 : Global Market for Cell Expansion, Academic and Research Institutes, by Region, Through 2027
  • Table 39 : Global Market for Cell Expansion for Clinical Laboratories and Hospitals, by Region, Through 2027
  • Table 40 : Global Market for Vectors, by Region, Through 2027
  • Table 41 : Global Market for Cancer Vectors, by Region, Through 2027
  • Table 42 : Global Market for Rare Disease Vectors, by Region, Through 2027
  • Table 43 : Global Market for Vectors for Other Diseases, by Region, Through 2027
  • Table 44 : Global Market for Vectors for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
  • Table 45 : Global Market for Vectors for Academic and Research Institutes, by Region, Through 2027
  • Table 46 : Global Market for Vectors for Clinical Laboratories and Hospitals, by Region, Through 2027
  • Table 47 : Global Market for GMP Small Molecules, by Region, Through 2027
  • Table 48 : Global Market for GMP Small Molecules for Cancer, by Region, Through 2027
  • Table 49 : Global Market for GMP Small Molecules for Rare Diseases, by Region, Through 2027
  • Table 50 : Global Market for GMP Small Molecules for Other Diseases, by Region, Through 2027
  • Table 51 : Global Market for GMP Small Molecules for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
  • Table 52 : Global Market for GMP Small Molecules for Academic and Research Institutes, by Region, Through 2027
  • Table 53 : Global Market for GMP Small Molecules for Clinical Laboratories and Hospitals, by Region, Through 2027
  • Table 54 : Global Market for GMP Antibodies, by Region, Through 2027
  • Table 55 : Global Market for GMP Antibodies for Cancer, by Region, Through 2027
  • Table 56 : Global Market for GMP Antibodies for Rare Diseases, by Region, Through 2027
  • Table 57 : Global Market for GMP Antibodies for Other Diseases, by Region, Through 2027
  • Table 58 : Global Market for GMP Antibodies for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
  • Table 59 : Global Market for GMP Antibodies for Academic and Research Institutes, by Region, Through 2027
  • Table 60 : Global Market for GMP Antibodies for Clinical Laboratories and Hospitals, by Region, Through 2027
  • Table 61 : Global Market for Leukapheresis, by Region, Through 2027
  • Table 62 : Global Market for Leukapheresis for Cancer, by Region, Through 2027
  • Table 63 : Global Market for Leukapheresis for Rare Diseases, by Region, Through 2027
  • Table 64 : Global Market for Leukapheresis for Other Diseases, by Region, Through 2027
  • Table 65 : Global Market for Leukapheresis for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
  • Table 66 : Global Market for Leukapheresis for Academic and Research Institutes, by Region, Through 2027
  • Table 67 : Global Market for Leukapheresis for Clinical Laboratories and Hospitals, by Region, Through 2027
  • Table 68 : Global Market for Cryopreservation, by Region, Through 2027
  • Table 69 : Global Market for Cryopreservation for Cancer, by Region, Through 2027
  • Table 70 : Global Market for Cryopreservation for Rare Diseases, by Region, Through 2027
  • Table 71 : Global Market for Cryopreservation for Other Diseases, by Region, Through 2027
  • Table 72 : Global Market for Cryopreservation for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
  • Table 73 : Global Market for Cryopreservation for Academic and Research Institutes, by Region, Through 2027
  • Table 74 : Global Market for Cryopreservation for Clinical Laboratories and Hospitals, by Region, Through 2027
  • Table 75 : Global Market for Bioreactors, by Region, Through 2027
  • Table 76 : Global Market for Bioreactors for Cancer, by Region, Through 2027
  • Table 77 : Global Market for Bioreactors for Rare Diseases, by Region, Through 2027
  • Table 78 : Global Market for Bioreactors for Other Diseases, by Region, Through 2027
  • Table 79 : Global Market for Bioreactors for Pharmaceutical & Biotechnology Companies, by Region, Through 2027
  • Table 80 : Global Market for Bioreactors for Academic and Research Institutes, by Region, Through 2027
  • Table 81 : Global Market for Bioreactors for Clinical Laboratories and Hospitals, by Region, Through 2027
  • Table 82 : Global Market for Research-Use-Only Immunoassays, by Region, Through 2027
  • Table 83 : Global Market for Research-Use-Only Multiplex Immunoassays, by Region, Through 2027
  • Table 84 : Global Market for Research-Use-Only Immunoassays for Cancer, by Region, Through 2027
  • Table 85 : Global Market for Research-Use-Only Immunoassays for Rare Diseases, by Region, Through 2027
  • Table 86 : Global Market for Research-Use-Only Immunoassays for Other Diseases, by Region, Through 2027
  • Table 87 : Global Market for Research-Use-Only Immunoassays for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
  • Table 88 : Global Market for Research-Use-Only Immunoassays for Academic and Research Institutes, by Region, Through 2027
  • Table 89 : Global Market for Research-Use-Only Immunoassays for Clinical Laboratories and Hospitals, by Region, Through 2027
  • Table 90 : Global Market for Research-Use-Only Multiplex Immunoassays for Cancer, by Region, Through 2027
  • Table 91 : Global Market for Research-Use-Only Multiplex Immunoassays for Rare Diseases, by Region, Through 2027
  • Table 92 : Global Market for Research-Use-Only Multiplex Immunoassays for Other Diseases, by Region, Through 2027
  • Table 93 : Global Market for Research-Use-Only Multiplex Immunoassays for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
  • Table 94 : Global Market for Research-Use-Only Multiplex Immunoassays for Academic and Research Institutes, by Region, Through 2027
  • Table 95 : Global Market for Research-Use-Only Multiplex Immunoassays for Clinical Laboratories and Hospitals, by Region, Through 2027
  • Table 96 : Global Market for Cytokine Release Testing, by Region, Through 2027
  • Table 97 : Global Market for Cytokine Release Testing for Cancer, by Region, Through 2027
  • Table 98 : Global Market for Cytokine Release Testing for Rare Diseases, by Region, Through 2027
  • Table 99 : Global Market for Cytokine Release Testing for Other Diseases, by Region, Through 2027
  • Table 100 : Global Market for Cytokine Release Testing for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
  • Table 101 : Global Market for Cytokine Release Testing for Academic and Research Institutes, by Region, Through 2027
  • Table 102 : Global Market for Cytokine Release Testing for Clinical Laboratories and Hospitals, by Region, Through 2027
  • Table 103 : Global Cell and Gene Therapy Tools and Reagents Market, by Region, Through 2027
  • Table 104 : Mergers and Acquisitions, 2020-2022
  • Table 105 : Competitive Analysis: Cell and Gene Therapy Tools and Reagents Market, 2021

List of Figures

  • Summary Figure A : Global Market for Cell and Gene Therapy Tools and Reagents, 2019-2027
  • Summary Figure B : Global Market for Cell and Gene Therapy Tools and Reagents, by Region, 2019-2027
  • Figure 1 : Global Cell and Gene Therapy Tools and Reagents Market, by Application, 2019-2027
  • Figure 2 : Global Cell and Gene Therapy Tools and Reagents, by Application, 2021
  • Figure 3 : Global Cell and Gene Therapy Tools and Reagents for Cancer, by Region, 2019-2027
  • Figure 4 : Global Cell and Gene Therapy Tools and Reagents for Rare Diseases, by Region, 2019-2027
  • Figure 5 : Global Cell and Gene Therapy Tools and Reagents for Other Diseases, by Region, 2019-2027
  • Figure 6 : Global Cell and Gene Therapy Tools and Reagents, by End User, 2019-2027
  • Figure 7 : Global Cell and Gene Therapy Tools and Reagents, by End User, 2021
  • Figure 8 : Private Investment, Cell and Gene Therapy, 2014-2021
  • Figure 9 : Global Cell and Gene Therapy Tools and Reagents for Pharmaceutical and Biotechnology Companies, by Region, 2019-2027
  • Figure 10 : Global Cell and Gene Therapy Tools and Reagents Market for Academic and Research Institutes, by Region, 2019-2027
  • Figure 11 : Global Cell and Gene Therapy Tools and Reagents Market for Clinical Laboratories, by Region, 2019-2027
  • Figure 12 : Global Cell and Gene Therapy Tools and Reagents Market, by Type, 2019-2027
  • Figure 13 : Global Cell and Gene Therapy Tools and Reagents Market, by Type, 2021
  • Figure 14 : Global Market for GMP Proteins, by Region, 2019-2027
  • Figure 15 : Global Market for Media, by Region, 2019-2027
  • Figure 16 : Global Market for Cell Separation, by Region, 2019-2027
  • Figure 17 : Global Market for Cell Expansion, by Region, 2019-2027
  • Figure 18 : Vectors Used in Gene Therapy Clinical Trials, 2018
  • Figure 19 : Global Market for Vectors, by Region, 2019-2027
  • Figure 20 : Global Market for GMP Small Molecules, by Region, 2019-2027
  • Figure 21 : Global Market for GMP Antibodies, by Region, 2019-2027
  • Figure 22 : Global Market for Leukapheresis, by Region, 2019-2027
  • Figure 23 : Global Market for Cryopreservation, by Region, 2019-2027
  • Figure 24 : Global Market for Bioreactors, by Region, 2019-2027
  • Figure 25 : Global Market for Research-Use-Only Immunoassays, by Region, 2019-2027
  • Figure 26 : Global Market for Research-Use-Only Multiplex Immunoassays, by Region, 2019-2027
  • Figure 27 : Global Market for Cytokine Release Testing, by Region, 2019-2027
  • Figure 28 : Global Cell and Gene Therapy Tools and Reagents Market, by Region, 2019-2027
  • Figure 29 : Global Cell and Gene Therapy Tools and Reagents Market, by Region, 2021
  • Figure 30 : U.S. Market for Cell and Gene Therapy Tools and Reagents, 2019-2027
  • Figure 31 : China Market for Cell and Gene Therapy Tools and Reagents, 2019-2027
  • Figure 32 : Bio-Rad Laboratories Inc.: Annual Revenue, 2019-2021
  • Figure 33 : Bio-Rad Laboratories Inc.: Market Share, by Business Segment, 2021
  • Figure 34 : Bio-Rad Laboratories Inc.: Revenue Share, by Region/Country, 2021
  • Figure 35 : Bio-Techne: Annual Revenue, 2019-2021
  • Figure 36 : Bio-Techne: Market Share, by Business Segment, 2021
  • Figure 37 : Bio-Techne: Revenue Share, by Region/Country, 2021
  • Figure 38 : Danaher Life Science Segment (including Cytiva): Annual Revenue, 2019-2021
  • Figure 39 : Danaher Life Sciences Segment (Including Cytiva): Market Share, by Region, 2021
  • Figure 40 : Merck KGaA Life Sciences Segment: Annual Revenue, 2019-2021
  • Figure 41 : Merck KGaA Life Sciences Segment: Revenue, by Region, 2021
  • Figure 42 : Merck KGaA Life Sciences Segment: Revenue Share, by Segment, 2021
  • Figure 43 : Sartorius: Annual Revenue, 2019-2021
  • Figure 44 : Sartorius: Market Share, by Region, 2021
  • Figure 45 : Sartorius: Market Share, by Business Segment, 2021
  • Figure 46 : Thermo Fisher Scientific Inc.: Annual Revenue, 2019-2021
  • Figure 47 : Thermo Fisher Scientific Inc.: Market Share, by Region, 2021
  • Figure 48 : Thermo Fisher Scientific Inc.: Market Share, by Business Segment, 2021
目次
Product Code: BIO208B

Highlights:

The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.

The North American market is estimated to grow from $3.7 billion in 2022 to $6.6 billion in 2027, with a CAGR of 12.2% for the period of 2022-2027.

The European market is estimated to grow from $2.1 billion in 2022 to $3.5 billion in 2027, with a CAGR of 10.2% for the period of 2022-2027.

Report Scope:

The scope of this study encompasses an investigation of cell and gene therapy tools: GMP proteins, media, cell separation and activation reagents, viral and non-viral, cytokine release syndrome monitoring products, GMP antibodies, leukapheresis instrumentation, immunoassays (multiplex and singleplex) and bioreactors. BCC Research analyzes each tool type, determines its current market status, examines its impact on future markets and presents forecasts of growth over the next six years. The current report provides detailed analysis of the market's drivers, challenges and opportunities. The report also covers market projections to 2027 and market share for key market players. The report includes the company profiles of key players with detailed information about business segments, financials, product portfolios and recent developments. The report provides impact analysis of the COVID-19 pandemic on this market.

Report Includes:

  • 105 total tables
  • An updated overview of the global market for immunoassay-based cell and gene therapy tools and reagents
  • Analyses of the global market trends, with historic market revenue for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the market potential for the cell and gene therapy tools and reagents in the life sciences industry, growth driving factors, and areas of focus to forecast this market into various segments and sub-segments
  • Estimation of actual market size and revenue forecast for cell and gene therapy tools and reagents in USD million terms, and corresponding market share analysis based on product, application/disease area, end-user, and region
  • In-depth information (facts and figures) concerning major market dynamics (DROs), product innovations, clinical trials, and various government regulations affecting the market outlook for cell and gene therapy tools and reagents
  • Review of prevalence of infectious disease, metabolic disorders and chronic ailments; along with the recent technological advancements, competitive environment, and the industry value chain analysis
  • Coverage of the technological, economic, and business considerations of the prevailing cell and gene therapy tools market, and its vendor landscape
  • Patent review and new developments, R&D efforts, industrial changes with emphasis on recent investments, and current state of the immunoassay technology
  • Identification of the companies best positioned to meet the demand for cell and gene therapy in life sciences applications owing to their proprietary technologies, novel product launches, key mergers and acquisition deals, and other strategic advantages
  • Descriptive company profiles of the market leading players, including Abcam, Akron Biotech, Adverum Biotechnologies and Avrobio.

Table of Contents

Chapter 1 Introduction

  • 1.1 Study Goals and Objectives
  • 1.2 Reasons for Doing This Study
  • 1.3 Scope of Report
  • 1.4 What's New in This Update?
  • 1.5 Information Sources
  • 1.6 Methodology
  • 1.7 Geographic Breakdown
  • 1.8 Analyst's Credentials
  • 1.9 BCC Custom Research
  • 1.10 Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • 3.1 Overview: Cell and Gene Therapy
    • 3.1.1 Cell Therapy
    • 3.1.2 Gene Therapy
  • 3.2 Types of Cell and Gene Therapy
    • 3.2.1 Gene Therapy
    • 3.2.2 Cell Therapy
    • 3.2.3 Evolution and Expansion of Therapies
    • 3.2.4 Common Equipment Used

Chapter 4 Market Dynamics

  • 4.1 Factors Affecting the Market
  • 4.2 Market Drivers
    • 4.2.1 Increasing Investment in CGT R&D
    • 4.2.2 Capacity Expansions for Clinical and Commercial Manufacturing
    • 4.2.3 Increasing Incidence of Chronic Diseases
    • 4.2.4 Increasing Strategic Collaborations and Acquisitions
    • 4.2.5 Market Restraints
    • 4.2.6 Complex Manufacturing and Supply Chain
    • 4.2.7 Lack of Skilled Workforce
    • 4.2.8 Market Opportunities
  • 4.3 Impact of COVID-19

Chapter 5 Market Breakdown, by Application

  • 5.1 Cell and Gene Therapy Tools and Reagents Market
  • 5.2 Cancer
  • 5.3 Rare Diseases
  • 5.4 Other Diseases

Chapter 6 Market Breakdown, by End User

  • 6.1 Biotechnology and Pharmaceutical Companies
  • 6.2 Academic and Research Institutes
  • 6.3 Clinical Laboratories/Hospitals
  • 6.4 GMP Proteins

Chapter 7 Market Breakdown, by Type

  • 7.1 GMP Proteins
    • 7.1.1 GMP Proteins by Application
    • 7.1.2 GMP Proteins, by End User
  • 7.2 Media
    • 7.2.1 Media by Application
    • 7.2.2 Media by End User
  • 7.3 Cell Separation
    • 7.3.1 Cell-Separation by Application
    • 7.3.2 Cell Separation by End User
  • 7.4 Cell Expansion
    • 7.4.1 Cell Expansion by Application
    • 7.4.2 Cell Expansion by End User
  • 7.5 Vectors
    • 7.5.1 Vectors by Application
    • 7.5.2 Vectors, by End User
  • 7.6 GMP Small Molecules
  • 7.6.1GMP Small Molecules by Application
    • 7.6.2 GMP Small Molecules, by End User
  • 7.7 GMP Antibodies
    • 7.7.1 GMP Antibodies, by Application
    • 7.7.2 GMP Antibodies, by End User
  • 7.8 Leukapheresis
    • 7.8.1 Leukapheresis, by Application
    • 7.8.2 Leukapheresis by End User
  • 7.9 Cryopreservation
    • 7.9.1 Cryopreservation, by Application
    • 7.9.2 Cryopreservation by End User
  • 7.10 Bioreactors
    • 7.10.1 Bioreactors, by Application
    • 7.10.2 Bioreactors, by End User
  • 7.11 Immunoassays and Multiplex Immunoassays
    • 7.11.1 Immunoassays, by Application
    • 7.11.2 Immunoassays, by End User
    • 7.11.3 Multiplex Immunoassays, by Application
    • 7.11.4 Multiplex Immunoassays, by End User
  • 7.12 Cytokine Release Testing
    • 7.12.1 Cytokine Release Testing, by Application
    • 7.12.2 Cytokine Release Testing by End User

Chapter 8 Market Breakdown by Region

  • 8.1 North America
  • 8.2 Europe
  • 8.3 Asia-Pacific
  • 8.4 Rest of the World

Chapter 9 Government Regulations

  • 9.1 Scope of Regulations on Gene Therapy
    • 9.1.1 Viral and Non-Viral Vectors
    • 9.1.2 Media
    • 9.1.3 GMP Proteins and Antibodies
    • 9.1.4 Cell Therapy
    • 9.1.5 Leukapheresis
    • 9.1.6 Cell Therapy, Gene Therapy and the EMA

Chapter 10 Patent Review/New Developments

  • 10.1 Cell and Gene Therapy R&D
    • 10.1.1 Academia
  • 10.2 Technology
    • 10.2.1 Key Patents

Chapter 11 Competitive Landscape

  • 11.1 Mergers and Acquisitions
    • 11.1.1 Strategic Initiatives
  • 11.2 Competitive Analysis

Chapter 12 Company Profiles

  • ABCAM
  • AKRON BIOTECH
  • ADVERUM BIOTECHNOLOGIES
  • ATHERSYS INC.
  • AVROBIO
  • BIO-RAD LABORATORIES
  • BIO-TECHNE
  • CELLGENIX
  • CYTIVA LIFE SCIENCES
  • FUJIFILM IRVINE SCIENTIFIC
  • LUMINEX CORP.
  • MESOBLAST LTD.
  • MERCK KGAA
  • MILTENYI BIOTEC
  • ORGANICELL
  • PROTEINTECH GROUP INC.
  • SARTORIUS
  • SINO BIOLOGICAL INC.
  • STEMCELL TECHNOLOGIES
  • THERMO FISHER SCIENTIFIC